Interpace Biosciences, Inc. (IDXG)
1.85
+0.03
(+1.65%)
USD |
OTCM |
Feb 12, 16:00
Interpace Biosciences Free Cash Flow : 4.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| FONAR Corp. | 7.016M |
| Thermo Fisher Scientific, Inc. | 6.294B |
| XWELL, Inc. | -15.12M |
| Hypha Labs, Inc. | -0.413M |
| Veracyte, Inc. | 98.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.938M |
| Cash from Investing (Quarterly) | -0.117M |
| Cash from Financing (Quarterly) | -0.90M |
| Free Cash Flow Per Share (Quarterly) | 0.0658 |
| Free Cash Flow to Equity (Quarterly) | 2.713M |
| Free Cash Flow to Firm (Quarterly) | 1.851M |
| Free Cash Flow Yield | 14.91% |